or Try an Advanced Search...

    Technical Analysis for BFRI - Biofrontera Inc.

    Grade Last Price % Change Price Change
    D 1.72 2.99% 0.05
    BFRI closed down 2.34 percent on Thursday, April 18, 2024, on 5 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical BFRI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 2.99%
    NR7 Range Contraction 2.99%
    Wide Bands Range Expansion 2.99%
    20 DMA Support Bullish 0.58%
    Wide Bands Range Expansion 0.58%
    MACD Bearish Signal Line Cross Bearish -5.42%
    20 DMA Support Bullish -5.42%
    Wide Bands Range Expansion -5.42%
    Wide Bands Range Expansion 4.88%
    Gapped Down Weakness 4.88%
    Older End-of-Day Signals for BFRI ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance about 1 hour ago
    20 DMA Support about 1 hour ago
    Gap Up Partially Closed about 1 hour ago
    Gapped Up (Partial) about 1 hour ago
    Rose Above 20 DMA about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BFRI Chart by TradingView
    Basic chart:

    Profile

    Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer

    Is BFRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 26 Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
    Mar 19 Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
    Mar 19 Q4 2023 Biofrontera Inc Earnings Call
    Mar 18 Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript
    Mar 18 Biofrontera GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1.21M
    Mar 16 CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
    Mar 15 Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
    Mar 15 Earnings Scheduled For March 15, 2024
    Mar 11 Biofrontera files to sell 9.31M shares of common stock for holders
    Mar 8 Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
    See more BFRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.42
    52 Week Low 0.61
    Average Volume 766,843
    200-Day Moving Average 4.94
    50-Day Moving Average 1.29
    20-Day Moving Average 1.70
    10-Day Moving Average 1.94
    Average True Range 0.28
    RSI (14) 50.25
    ADX 27.4
    +DI 27.75
    -DI 21.81
    Chandelier Exit (Long, 3 ATRs) 1.59
    Chandelier Exit (Short, 3 ATRs) 1.86
    Upper Bollinger Bands 2.43
    Lower Bollinger Band 0.97
    Percent B (%b) 0.48
    BandWidth 85.45
    MACD Line 0.14
    MACD Signal Line 0.17
    MACD Histogram -0.0361
    Fundamentals Value
    Market Cap 2.81 Million
    Num Shares 1.68 Million
    EPS -20.36
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 0.04
    Price-to-Book 1.18
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.93
    Resistance 3 (R3) 1.95 1.88 1.88
    Resistance 2 (R2) 1.88 1.82 1.87 1.87
    Resistance 1 (R1) 1.78 1.77 1.74 1.76 1.85
    Pivot Point 1.71 1.71 1.69 1.70 1.71
    Support 1 (S1) 1.61 1.65 1.57 1.59 1.49
    Support 2 (S2) 1.54 1.60 1.53 1.47
    Support 3 (S3) 1.44 1.54 1.46
    Support 4 (S4) 1.42